NCT06230445

Effects of Digital Therapeutic in Whole Process Management of Lung Cancer

A Phase 3, Randomized, Open-label Trial of Digital Therapeutic vs Regular Follow-up in Whole Process Management of Lung Cancer

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 900 (estimated)
• Sponsor: Sun Yat-sen University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

This trial will randomize patients into two groups, the treatment group will use the digital therapeutic application named 'UHealth' for the whole process management and the control group will use regular follow-up. The trial aims to look into the difference between quality of life, anxiety/depression index, emergency treatment times, hospital admission rate, treatment compliance, OS, DFS and follow-up cost.

Conditions

• Application of Digital Therapeutic in Lung Cancer Whole Process Management

Interventions

Type	Name	Description
OTHER	UHealth digital therapeutic	UHealth digital therapeutic is an application that patients can report their symptoms. If the contents that patients fill in reach the threshold, UHealth application will automatic report to doctor and the doctor will give medical advisement through UHealth digital therapeutic application.

Timeline

• Start date: 2023-06-01
• Primary completion: 2026-03-01
• Completion: 2028-09-01
• First posted: 2024-01-30
• Last updated: 2024-02-26

Locations

1 site across 1 country: China